4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-25-027201
Chief Operating Officer returned 5,636 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Castle Jeremy Chief Operating Officer | 2025-05-21 | Returned to the company | −5,636 | $2.68 | $15,076 | 247,031 | D |
Loading xslF345X05/wk-form4_1747936763.xml…